Research UMC Utrecht on rare lung diseases with biotechnology and AI
Health-Holland has awarded a three-million-euro grant to Kors van der Ent, professor of paediatric lung diseases (UMC Utrecht) for the PRO-Long research. Kors and his team are investigating how to use biotechnology to develop innovative therapies. They focus on patients with rare lung diseases, such as cystic fibrosis and Primary Ciliary Dyskinesia.
In the Netherlands, more than 1.2 million people have chronic lung disease. Hereditary factors play a role in almost all lung diseases, and some lung diseases (such as Cystic Fibrosis and Primary Ciliary Dyskinesia) are even completely determined by genetic defects. People with these conditions are often ill and often hospitalised. The associated annual healthcare costs amount to about EUR 4 billion. Moreover, these people often die at a younger age.
The aim of this PRO-Long research is to develop mRNA and gene therapy in human stem cells, using biotechnology and artificial intelligence. This will allow people with lung diseases to be treated faster and more effectively. UMC Utrecht is not conducting this research alone, but together with Amsterdam UMC, two health funds and Lung Alliance Netherlands.
Kors van der Ent: ‘In the laboratory, we test new drugs directly on the cells of patients with rare hereditary lung diseases. We accelerate that process and make it better and better. But we also make sure, together with patient organisations, that patients are well informed as soon as a drug is very promising. In this way, we make the road from laboratory to the consulting room much shorter.’
With this programme, UMC Utrecht also encourages scientists and companies to keep the Netherlands at the forefront of these developments and make the Netherlands a magnet for new knowledge and economic activity.
About Health-Holland
Health-Holland promotes scientific discoveries and technological innovations that contribute to healthcare and life sciences (e.g. food production). Health-Holland also stimulates scientific discoveries and technological innovations that contribute to sustainable and structural economic growth.
UMC Utrecht takes third surgical robot into use
UMC Utrecht has commissioned a third surgical robot. With the arrival of the latest generation, the Da Vinci 5, even more patients can be operated on with minimal stress. This leads to fewer complications and faster recovery. “Apart from the benefits for patients, the Da Vinci 5 also allows us to train even better,” says Jelle Ruurda, gastrointestinal surgeon and professor of robot-assisted minimally invasive surgery. “At the touch of a button, colleagues can watch remotely, and even learn from previous operations. This way we share knowledge faster and more widely.” The hospital is thus building on a tradition of 25 years at the forefront of robotic surgery.
The HU ORM program is moving to the Utrecht Science Park.
The Entrepreneurship & Retail Management (ORM) program will relocate from Amersfoort to the Utrecht Science Park as of September 1, 2026. According to program manager Lisette Luijk (Institute for Marketing & Commerce), it is mainly about one thing: more connection.
Danny Sahtoe receives NVBMB prize
Danny Sahtoe has been awarded the prestigious NVBMB prize, a prize that gives recognition to the work of a highly talented young independent researcher in the field of biochemistry or molecular biology. The prize includes funding to organize a one-day symposium on a topic of choice. Danny Sahtoe is group leader at the Hubrecht Institute and Investigator at Oncode Institute.
Inspiring and connecting visit by the President of Estonia to Utrecht Science Park
On Wednesday, April 8, 2026, the President of Estonia, Mr. Alar Karis, together with his wife Sirje Karis, ambassador Mr. Paul Teesalu and a delegation from the Estonian Health Ecosystem, visited the Utrecht Science Park. During the visit, much knowledge was exchanged and valuable connections were made.